SCHEMBL21036192

SCHEMBL21036192

COC(=O)[C@@H]1C[C@H](Oc2ccc(Cl)cc2)CN1S(=O)(=O)c1ccc(OCC2CCCCC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 9/20 0.42
ADAM17 P78536 2/20 0.42
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MMP3 P08254 9/20 0.41
MMP9 P14780 1/20 0.41
MMP7 P09237 6/20 0.41
MMP13 P45452 6/20 0.41
RGS12 O14924 1/20 0.40
TSHR P16473 1/20 0.40
MMP2 P08253 3/20 0.40
HCRTR1 O43613 2/20 0.39
HCRTR2 O43614 2/20 0.39
BCL2L1 Q07817 1/20 0.39
MCL1 Q07820 1/20 0.39
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
KCNQ1 P51787 1/20 0.39
FKBP1A P62942 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21034928 1.00 MMP1 (0.42) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035335 0.92 MMP1 (0.47) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035339 0.92 MMP1 (0.47) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035336 0.92 MMP1 (0.47) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035579 0.90 MMP1 (0.42) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21034930 0.90 MMP1 (0.42) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035125 0.90 MMP1 (0.46) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035575 0.90 MMP1 (0.46) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035083 0.90 MMP1 (0.46) MMP1ADAM17KMT2ANPSR1MMP3
SCHEMBL21035659 0.90 MMP1 (0.46) MMP1ADAM17KMT2ANPSR1MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed